Objectives: INOCA (Ischemia in non- obstructive coronary arteries) has been recognized as a global health problem and poses a diagnostic challenge to establish the diagnosis which involves first ruling out obstructive coronary artery disease by the use of CT coronary angiography (CTCA) or an invasive angiogram. Second step involves the use of intracoronary pressure and Doppler monitoring which is not only costly, time consuming and lacks easy availability. CTFFR has emerged as frontline tool in the non invasive evaluation of patients with stable chest pain. This retrospective study was designed to evaluate the spectrum of findings of ischemia on CTCA and CT FFR in patients with stable chest pain to determine if this protocol can be used to identify patients with INOCA before they are subjected to invasive protocol. Methods: This was a retrospective study of 500 consecutive patients of stable chest pain with more than >1mm ST depression on resting EKG and or positive stress test who underwent CTCA along with CTFFR evaluation using a prescribed CT angiographic protocol. Post processing was done to reconstruct multiplanar angiographic views followed by CT FFR evaluation. All patients with no obstruction or stenosis less than 50% and with CT FFR of <0.80 were labeled as having INOCA. Subcategorisation of all INOCA patients was done based on Vessel tapering index (VTI), Plaque volume Index (PVI) into four subtypes- TypeI (vasospastic), Type II (site specific atherosclerotic), Type III (distal macrovascular dysfunction- DMD), Type IV (mixed). Results: Study showed 122 (34%) patients of stable chest pain had INOCA. Types I, III formed the largest group of patients 38% and 31% followed by the other two subtypes and showed significant differences in the VTI and PVI along with reduced FFR of <.80 in all these patients. Conclusion: Use of CTCA and CTFFR can be used as a first line tool to not only rule out obstructive coronary disease with ischemia but also to non invasively detect INOCA in patients with stable chest pain before subjecting these patients for further invasive protocols and can influence accurate management of such patients.
Published in | Cardiology and Cardiovascular Research (Volume 5, Issue 2) |
DOI | 10.11648/j.ccr.20210502.13 |
Page(s) | 67-73 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
INOCA, CTFFR, CT Coronary Angiography
[1] | GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the GlobalBurden of Disease Study 2015. Lancet. 2016; 388: 1459-1544. |
[2] | Reeh J, Therming CB, Heitmann M, Hojberg S, Sorum C, Bech J, Husum D, Dominguez H, Sehestedt T, Hermann T, Hansen KW, Simonsen L, Galatius S, Prescott E. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J. 2019; 40: 1426-1435. |
[3] | Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J. 2005; 27: 1408-1415. |
[4] | Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas AH, Prescott E et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group European Heart Journal (2020) 41, 3504–3520. |
[5] | Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007; 356: 830-840. |
[6] | Widmer RJ, Samuels B, Samady H, Price MJ, Jeremias A, Anderson RD, Jaffer FA, Escaned J, Davies J, Prasad M, Grines C, Lerman A. The functional assessment of patients with non-obstructive coronary artery disease: expert review from an international microcirculation working group. EuroIntervention. 2019; 14: 1694-1702. |
[7] | Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P, WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017 Jan 14; 38 (3): 143-153. |
[8] | Kelion AD, Nicol ED. The rationale for the Primacy of coronary CT angiography in the National Institute for health and care excellence (NICE) guideline (CG95) for the investigation of chest pain of recent onset. J Cardiovasc Comput Tomogr 2018; 12: 516–22. |
[9] | Tavella R, Cutri N, Tucker G, et al. Natural history of patients with insignificant coronary artery disease. Eur Heart J Qual Care Clin Outcomes 2016; 2: 117–24. |
[10] | Lin F, Gianni U, Lu Y, Stuijfzand, Bax AM, Hollenberg EJ. Macrovascular abnormalities and FFRCT in ISCHEMIA with non obstructive coronary arteries (INOCA): The Credence Trial. J Am CollCardiol. 2020 Mar, 75 (11_Supplement_1) 22. |
[11] | Sidik NP, McEntegart M, Roditi G, Ford TJ, McDermott M, Morrow A, Byrne J, Adams J, Hargreaves A, Oldroyd KG, Stobo D, Wu O, Messow CM, McConnachie A, Berry C. Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study. Am Heart J. 2020; 221: 48-59. |
[12] | Ford TJ, Stanley B, Good R, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J Am Coll Cardiol. 2018; 72 (23 Pt A): 2 841-2855. |
[13] | Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Bairey Merz CN; Coronary Vasomotion Disorders International Study Group (COVADIS). International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2015; 38: 2565–2568. |
[14] | Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation 2011; 124: 1774–1782. |
[15] | Stegehius V, Wijntjens, VandeHoef TP, Casadonte L, Kirkeeide RL et al. Distal Evaluation of Functionalperformance with Intravascular sensors to assess the Narrowing Effect—combined pressure and Doppler FLOW velocity measurements (DEFINE-FLOW) trial: Rationale and trial design. American Heart Journal. 2020; 222: 139-145. |
APA Style
Atul Kapoor, Goldaa Mahajan, Aprajita Kapur. (2021). Use of CTFFR and CTCA to Diagnose and Triage Patients of INOCA: A Retrospective Study. Cardiology and Cardiovascular Research, 5(2), 67-73. https://doi.org/10.11648/j.ccr.20210502.13
ACS Style
Atul Kapoor; Goldaa Mahajan; Aprajita Kapur. Use of CTFFR and CTCA to Diagnose and Triage Patients of INOCA: A Retrospective Study. Cardiol. Cardiovasc. Res. 2021, 5(2), 67-73. doi: 10.11648/j.ccr.20210502.13
AMA Style
Atul Kapoor, Goldaa Mahajan, Aprajita Kapur. Use of CTFFR and CTCA to Diagnose and Triage Patients of INOCA: A Retrospective Study. Cardiol Cardiovasc Res. 2021;5(2):67-73. doi: 10.11648/j.ccr.20210502.13
@article{10.11648/j.ccr.20210502.13, author = {Atul Kapoor and Goldaa Mahajan and Aprajita Kapur}, title = {Use of CTFFR and CTCA to Diagnose and Triage Patients of INOCA: A Retrospective Study}, journal = {Cardiology and Cardiovascular Research}, volume = {5}, number = {2}, pages = {67-73}, doi = {10.11648/j.ccr.20210502.13}, url = {https://doi.org/10.11648/j.ccr.20210502.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210502.13}, abstract = {Objectives: INOCA (Ischemia in non- obstructive coronary arteries) has been recognized as a global health problem and poses a diagnostic challenge to establish the diagnosis which involves first ruling out obstructive coronary artery disease by the use of CT coronary angiography (CTCA) or an invasive angiogram. Second step involves the use of intracoronary pressure and Doppler monitoring which is not only costly, time consuming and lacks easy availability. CTFFR has emerged as frontline tool in the non invasive evaluation of patients with stable chest pain. This retrospective study was designed to evaluate the spectrum of findings of ischemia on CTCA and CT FFR in patients with stable chest pain to determine if this protocol can be used to identify patients with INOCA before they are subjected to invasive protocol. Methods: This was a retrospective study of 500 consecutive patients of stable chest pain with more than >1mm ST depression on resting EKG and or positive stress test who underwent CTCA along with CTFFR evaluation using a prescribed CT angiographic protocol. Post processing was done to reconstruct multiplanar angiographic views followed by CT FFR evaluation. All patients with no obstruction or stenosis less than 50% and with CT FFR of <0.80 were labeled as having INOCA. Subcategorisation of all INOCA patients was done based on Vessel tapering index (VTI), Plaque volume Index (PVI) into four subtypes- TypeI (vasospastic), Type II (site specific atherosclerotic), Type III (distal macrovascular dysfunction- DMD), Type IV (mixed). Results: Study showed 122 (34%) patients of stable chest pain had INOCA. Types I, III formed the largest group of patients 38% and 31% followed by the other two subtypes and showed significant differences in the VTI and PVI along with reduced FFR of <.80 in all these patients. Conclusion: Use of CTCA and CTFFR can be used as a first line tool to not only rule out obstructive coronary disease with ischemia but also to non invasively detect INOCA in patients with stable chest pain before subjecting these patients for further invasive protocols and can influence accurate management of such patients.}, year = {2021} }
TY - JOUR T1 - Use of CTFFR and CTCA to Diagnose and Triage Patients of INOCA: A Retrospective Study AU - Atul Kapoor AU - Goldaa Mahajan AU - Aprajita Kapur Y1 - 2021/05/14 PY - 2021 N1 - https://doi.org/10.11648/j.ccr.20210502.13 DO - 10.11648/j.ccr.20210502.13 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 67 EP - 73 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20210502.13 AB - Objectives: INOCA (Ischemia in non- obstructive coronary arteries) has been recognized as a global health problem and poses a diagnostic challenge to establish the diagnosis which involves first ruling out obstructive coronary artery disease by the use of CT coronary angiography (CTCA) or an invasive angiogram. Second step involves the use of intracoronary pressure and Doppler monitoring which is not only costly, time consuming and lacks easy availability. CTFFR has emerged as frontline tool in the non invasive evaluation of patients with stable chest pain. This retrospective study was designed to evaluate the spectrum of findings of ischemia on CTCA and CT FFR in patients with stable chest pain to determine if this protocol can be used to identify patients with INOCA before they are subjected to invasive protocol. Methods: This was a retrospective study of 500 consecutive patients of stable chest pain with more than >1mm ST depression on resting EKG and or positive stress test who underwent CTCA along with CTFFR evaluation using a prescribed CT angiographic protocol. Post processing was done to reconstruct multiplanar angiographic views followed by CT FFR evaluation. All patients with no obstruction or stenosis less than 50% and with CT FFR of <0.80 were labeled as having INOCA. Subcategorisation of all INOCA patients was done based on Vessel tapering index (VTI), Plaque volume Index (PVI) into four subtypes- TypeI (vasospastic), Type II (site specific atherosclerotic), Type III (distal macrovascular dysfunction- DMD), Type IV (mixed). Results: Study showed 122 (34%) patients of stable chest pain had INOCA. Types I, III formed the largest group of patients 38% and 31% followed by the other two subtypes and showed significant differences in the VTI and PVI along with reduced FFR of <.80 in all these patients. Conclusion: Use of CTCA and CTFFR can be used as a first line tool to not only rule out obstructive coronary disease with ischemia but also to non invasively detect INOCA in patients with stable chest pain before subjecting these patients for further invasive protocols and can influence accurate management of such patients. VL - 5 IS - 2 ER -